NO810962L - Fremgangsmaate for fremstilling av nye derivater av tioformamid - Google Patents

Fremgangsmaate for fremstilling av nye derivater av tioformamid

Info

Publication number
NO810962L
NO810962L NO810962A NO810962A NO810962L NO 810962 L NO810962 L NO 810962L NO 810962 A NO810962 A NO 810962A NO 810962 A NO810962 A NO 810962A NO 810962 L NO810962 L NO 810962L
Authority
NO
Norway
Prior art keywords
mixture
solution
minutes
pyridyl
kpa
Prior art date
Application number
NO810962A
Other languages
English (en)
Norwegian (no)
Inventor
Jean-Claude Aloup
Jean Bouchaudon
Daniel Farge
Claude James
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of NO810962L publication Critical patent/NO810962L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Toys (AREA)
  • Lasers (AREA)
  • Instructional Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cephalosporin Compounds (AREA)
NO810962A 1980-08-18 1981-03-20 Fremgangsmaate for fremstilling av nye derivater av tioformamid NO810962L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8018035A FR2488609A1 (fr) 1980-08-18 1980-08-18 Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent

Publications (1)

Publication Number Publication Date
NO810962L true NO810962L (no) 1982-02-19

Family

ID=9245232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810962A NO810962L (no) 1980-08-18 1981-03-20 Fremgangsmaate for fremstilling av nye derivater av tioformamid

Country Status (24)

Country Link
US (1) US4379154A (de)
EP (2) EP0046417B1 (de)
JP (1) JPS5742687A (de)
KR (1) KR850001043B1 (de)
AT (1) ATE14730T1 (de)
CA (1) CA1161039A (de)
DE (1) DE3161861D1 (de)
DK (1) DK158735C (de)
ES (2) ES501060A0 (de)
FI (1) FI810835L (de)
FR (1) FR2488609A1 (de)
GR (1) GR72767B (de)
HU (1) HU187325B (de)
IE (1) IE51263B1 (de)
IL (1) IL62380A (de)
MA (1) MA19106A1 (de)
NO (1) NO810962L (de)
NZ (1) NZ197071A (de)
OA (1) OA06767A (de)
PH (1) PH16520A (de)
PL (2) PL130530B1 (de)
PT (1) PT72718B (de)
SU (2) SU1093248A3 (de)
ZA (1) ZA813159B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511371A1 (fr) * 1981-08-11 1983-02-18 Rhone Poulenc Sante Nouveaux nitriles heterocycliques, leur preparation et leur utilisation pour la preparation de medicaments
FR2528849B1 (fr) * 1982-06-17 1985-06-21 Rhone Poulenc Sante Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent
FR2573428B1 (fr) * 1984-11-20 1987-01-30 Rhone Poulenc Sante Nouveaux derives de la thioformamide, leur preparation et les medicaments qui les contiennent
GB8907306D0 (en) * 1989-03-31 1989-05-17 May & Baker Ltd New compositions of matter
FR2653770B1 (fr) * 1989-10-31 1992-01-03 Rhone Poulenc Sante Procede de preparation de (pyridyl-3)-2 tetrahydrothiopyrannecarbothioamide-2-oxydes-1-(1r,2r), les (pyridyl-3)-2 tetrhydrothiopyrannecarbothioamide-2-oxydes-1-(1r,2r) ainsi obtenus et les compositions pharmaceutiques qui les contiennent.
JPH04211048A (ja) * 1990-03-05 1992-08-03 Mitsubishi Kasei Corp チオカルバモイルアセトニトリル誘導体
HUT66229A (en) * 1991-10-14 1994-10-28 Eisai Co Ltd Thioformamide derivatives and process for producing them and pharmaceutical compositions containing them
US5625068A (en) * 1995-06-05 1997-04-29 American Cyanamid Company Substituted quinoline herbicide intermediates and process

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100970B1 (de) * 1970-07-30 1975-08-01 Fujisawa Pharmaceutical Co
DK627174A (de) * 1974-01-17 1975-09-08 Ciba Geigy Ag
FR2452488A1 (fr) * 1979-03-30 1980-10-24 Rhone Poulenc Ind Nouveaux derives du (pyridyl-2)-2 tetrahydrothiophene, leur preparation et les medicaments qui les contiennent
IE49570B1 (en) * 1979-03-30 1985-10-30 Rhone Poulenc Ind 2-(pyrid-2-yl)tetrahydrothiophene derivatives
JPS6134433A (ja) * 1984-08-31 1986-02-18 Nippon Telegr & Teleph Corp <Ntt> ｘｙ平面位置決め用アクチユエ−タ装置

Also Published As

Publication number Publication date
HU187325B (en) 1985-12-28
ES8301475A1 (es) 1982-12-01
DE3161861D1 (en) 1984-02-16
MA19106A1 (fr) 1981-10-01
EP0077083B1 (de) 1985-08-07
OA06767A (fr) 1982-12-31
SU1209029A3 (ru) 1986-01-30
IL62380A0 (en) 1981-05-20
PT72718A (fr) 1981-04-01
JPS5742687A (en) 1982-03-10
US4379154A (en) 1983-04-05
PL130679B1 (en) 1984-08-31
PL130530B1 (en) 1984-08-31
NZ197071A (en) 1983-07-15
FR2488609B1 (de) 1984-05-04
EP0077083A1 (de) 1983-04-20
ES503727A0 (es) 1982-12-01
FR2488609A1 (fr) 1982-02-19
ES8202819A1 (es) 1982-02-01
IE811036L (en) 1982-02-18
ATE14730T1 (de) 1985-08-15
DK158735B (da) 1990-07-09
EP0046417B1 (de) 1984-01-11
DK158735C (da) 1990-12-03
PH16520A (en) 1983-11-10
SU1093248A3 (ru) 1984-05-15
ES501060A0 (es) 1982-02-01
FI810835A7 (fi) 1982-02-19
KR850001043B1 (ko) 1985-07-19
JPH0259150B2 (de) 1990-12-11
PT72718B (fr) 1982-03-24
ZA813159B (en) 1983-07-27
KR830006277A (ko) 1983-09-20
IL62380A (en) 1984-11-30
EP0046417A1 (de) 1982-02-24
FI810835L (fi) 1982-02-19
GR72767B (de) 1983-12-02
PL230552A1 (de) 1982-03-01
CA1161039A (fr) 1984-01-24
IE51263B1 (en) 1986-11-26
DK130781A (da) 1982-02-19

Similar Documents

Publication Publication Date Title
JP4533466B2 (ja) 蛋白質イソプレニルトランスフェラーゼの阻害剤
CA2223062C (en) 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
DE69434041T2 (de) Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
CA2256022C (en) 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
AU2008293038B2 (en) Inhibitors of protein tyrosine kinase activity
AU782114B2 (en) Quinuclidine compounds and drugs containing the same as the active ingredient
US7060721B1 (en) Imidazole compounds and medicinal use thereof
EP0154190A1 (de) Pyridone
CA2134865A1 (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
JPH0784470B2 (ja) 活性化合物、その製法及びそれを含む医薬組成物
KR100929942B1 (ko) Ｍｇｌｕｒ５ 길항제로서 피리딘-2-카복사미드 유도체
CA2234967A1 (en) Fibrinogen receptor antagonists
EP1740569A1 (de) Imidazol-derivate als tafia-inhibitoren
CH666033A5 (de) 1,4-dihydropyridinderivate und deren salze und hydrate, verfahren zur herstellung dieser verbindungen und solche verbindungen enthaltende pharmazeutische praeparate.
DK158735B (da) Analogifremgangsmaade til fremstilling af heterocyclisk substituerede, oxygen- og/eller svovlholdige heterocycliske carbothioamid-derivater
NO863228L (no) Fremgangsmaate for fremstilling av farmakodynamisk aktive benzimidazol-derivater.
NO832184L (no) Fremgangsmaate for fremstilling av nye derivater av tioformamid
FI66862C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-(pyridyl-2)-tetrahydrotiofenderivat
SA05260027B1 (ar) مركبات بيريدين
EP0095104B1 (de) Verfahren zur Herstellung von Pyridyl- und Chinolinimidazolinonen
NZ206808A (en) Pyrrole derivatives
Barluenga et al. 2-Aza 1, 3-dienes: a new and simple method for the synthesis of functionalized pyridine derivatives
DK158949B (da) Heterocyclisk substituerede, oxygen- eller svovlholdige heterocycliske nitriler og deres anvendelse til fremstilling af tilsvarende heterocycliske thioformamidforbindelser
SU1037840A3 (ru) Способ получени производных 2-/2-пиридил/-тетрагидротиофена
AU2003267000A1 (en) 2-thio-substituted imidazole derivatives and their use in pharmaceutics